Efficacy and Safety of Dapagliflozin in Men and Women With Heart Failure With Reduced Ejection Fraction: A Prespecified Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial

IMPORTANCE: Women may respond differently to certain treatments for heart failure (HF) with reduced ejection fraction (HFrEF) than men. OBJECTIVE: To investigate the efficacy and safety of dapagliflozin compared with placebo in men and women with HFrEF enrolled in the Dapagliflozin and Prevention of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Butt, Jawad H., Docherty, Kieran F., Petrie, Mark C., Schou, Morten, Kosiborod, Mikhail N., O’Meara, Eileen, Katova, Tzvetana, Ljungman, Charlotta E. A., Diez, Mirta, Ogunniyi, Modele O., Langkilde, Anna Maria, Sjöstrand, Mikaela, Lindholm, Daniel, Bengtsson, Olof, Martinez, Felipe A., Ponikowski, Piotr, Sabatine, Marc S., Solomon, Scott D., Jhund, Pardeep S., McMurray, John J. V., Køber, Lars
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8014207/
https://ncbi.nlm.nih.gov/pubmed/33787831
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2021.0379
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados